A Phase 1/2a Study of K-1728 in Advanced Solid Tumors

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This first-in-human, open-label, multicenter study evaluates K-1728 administered as monotherapy and in combination in participants with advanced or metastatic solid tumors. The study assesses the safety, tolerability, pharmacokinetics, and preliminary antitumor activity of K-1728.
Epistemonikos ID: aa73e23b9a05bb620905ed6cf4efc3bace3c7186
First added on: Oct 07, 2026